Cargando…

Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function

Rapamycin/interleukin-2 (IL-2) combination treatment of NOD mice effectively treats autoimmune diabetes. We performed a phase 1 clinical trial to test the safety and immunologic effects of rapamycin/IL-2 combination therapy in type 1 diabetic (T1D) patients. Nine T1D subjects were treated with 2–4 m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, S. Alice, Rieck, Mary, Sanda, Srinath, Bollyky, Jennifer B., Samuels, Peter L., Goland, Robin, Ahmann, Andrew, Rabinovitch, Alex, Aggarwal, Sudeepta, Phippard, Deborah, Turka, Laurence A., Ehlers, Mario R., Bianchine, Peter J., Boyle, Karen D., Adah, Steven A., Bluestone, Jeffrey A., Buckner, Jane H., Greenbaum, Carla J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Immunology and Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425404/ https://www.ncbi.nlm.nih.gov/pubmed/22721971 http://dx.doi.org/10.2337/db12-0049

Ejemplares similares

Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
por: Herold, Kevan C., et al.
Publicado: (2013)

Nonviral-Mediated Hepatic Expression of IGF-I Increases Treg Levels and Suppresses Autoimmune Diabetes in Mice
por: Anguela, Xavier M., et al.
Publicado: (2013)

Treg-Specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T-Cell Stability
por: Thirawatananond, Puchong, et al.
Publicado: (2023)

Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4(+)CD25(+)FOXP3(+) Regulatory T-Cells
por: Monti, Paolo, et al.
Publicado: (2008)

Following the Fate of One Insulin-Reactive CD4 T cell: Conversion Into Teffs and Tregs in the Periphery Controls Diabetes in NOD Mice
por: Fousteri, Georgia, et al.
Publicado: (2012)

Transient and late-life rapamycin for healthspan extension
por: Quarles, Ellen K., et al.
Publicado: (2020)

Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4(+)CD25(+) Regulatory T-Cells of Type 1 Diabetic Subjects
por: Long, S. Alice, et al.
Publicado: (2010)

All-trans Retinoic Acid Inhibits Type 1 Diabetes by T Regulatory (Treg)-Dependent Suppression of Interferon-γ–Producing T-cells Without Affecting Th17 Cells
por: Van, Yang-Hau, et al.
Publicado: (2009)

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA(1c), and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
por: Haller, Michael J., et al.
Publicado: (2019)

Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes
por: Putnam, Amy L., et al.
Publicado: (2009)

Do kidney transplantations save money? A study using a before–after design and multiple register-based data from Sweden
por: Jarl, Johan, et al.
Publicado: (2018)

Perioperative management of adult cadaveric and live donor renal transplantation in the UK: a survey of national practice
por: Morkane, Clare M, et al.
Publicado: (2019)

A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes
por: Herold, Kevan C., et al.
Publicado: (2005)

Successful kidney transplantation normalizes platelet function
por: Kennedy, Claire, et al.
Publicado: (2018)

Cumulative incidence of subsequent malignancy after allo-HCT conditioned with or without low-dose total body irradiation
por: Nunez, Lina, et al.
Publicado: (2022)

Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease
por: Kim, Haesook T., et al.
Publicado: (2022)

EASIX-1year and late mortality after allogeneic stem cell transplantation
por: Kordelas, Lambros, et al.
Publicado: (2023)

Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes
por: Fiorina, Paolo, et al.
Publicado: (2008)

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease
por: Vickers, Mark A, et al.
Publicado: (2014)

The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
por: Alfred, Arun, et al.
Publicado: (2017)

Recognition of Posttranslationally Modified GAD65 Epitopes in Subjects With Type 1 Diabetes
por: McGinty, John W., et al.
Publicado: (2014)

Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use
por: Weber, Daniela, et al.
Publicado: (2022)

Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes
por: Xue, Song, et al.
Publicado: (2015)

Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL
por: Aldoss, Ibrahim, et al.
Publicado: (2022)

Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin
por: Strauss, Laura, et al.
Publicado: (2009)

Designing a Liver Transplant Patient and Family Decision Support Tool for Organ Offer Decisions
por: Schaffhausen, Cory R., et al.
Publicado: (2021)

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
por: Menghrajani, Kamal, et al.
Publicado: (2022)

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
por: Tamari, Roni, et al.
Publicado: (2023)

Peripherally Induced Tregs – Role in Immune Homeostasis and Autoimmunity
por: Yadav, Mahesh, et al.
Publicado: (2013)

Comparative Study of Immunomodulatory Agents to Induce Human T Regulatory (Treg) Cells: Preferential Treg-Stimulatory Effect of Prednisolone and Rapamycin
por: Janyst, Michał, et al.
Publicado: (2020)

Capture and enrichment of CD34-positive haematopoietic stem and progenitor cells from blood circulation using P-selectin in an implantable device
por: Wojciechowski, Joel C, et al.
Publicado: (2008)

Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effects
por: Abramowicz, Daniel, et al.
Publicado: (2008)

Risk factors for polyoma virus nephropathy
por: Prince, Olivier, et al.
Publicado: (2009)

Benefit of kidney transplantation beyond 70 years of age
por: Heldal, Kristian, et al.
Publicado: (2010)

Pancreas transplantation: differences in activity between Europe and the United States
por: Manuel González-Posada, José, et al.
Publicado: (2009)

Improvement in kidney transplantation in the Balkans after the Istanbul Declaration: where do we stand today?
por: Spasovski, Goce, et al.
Publicado: (2016)

Reciprocating living kidney donor generosity: tax credits, health insurance and an outcomes registry
por: Joshi, Shivam, et al.
Publicado: (2016)

A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants
por: Jardine, Laura, et al.
Publicado: (2015)

Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets
por: Bhatti, Adnan Bashir, et al.
Publicado: (2015)

BK polyoma virus infection and renal disease in non-renal solid organ transplantation
por: Kuppachi, Sarat, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m2bkct2uqbekum13me9a5vrqq6